ArticleTransplantation research2013

Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol.

Richard Haynes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.